Alfuzosin is an alpha-1 blocker used to treat benign prostatic hyperplasia (BPH). It relaxes the muscles in the prostate and bladder neck, improving urinary flow. It does not reduce prostate size but relieves symptoms like difficulty urinating and frequency. Common side effects include dizziness and hypotension.
Cleanchem is a trusted provider of premium pharmaceutical reference materials, specializing in Alfuzosin and its associated compounds. Our catalog includes pharmacopeial and non-pharmacopeial Alfuzosin impurities, metabolites, nitrosamine derivatives (N-NO compounds), and stable isotope-labeled products. These reference standards play a critical role in pharmaceutical R&D, supporting activities such as product formulation, ANDA and DMF submissions, quality assurance, analytical method development, and stability assessments.
All Alfuzosin-related substances undergo comprehensive characterization and are delivered with complete Certificates of Analysis and supporting analytical documentation to ensure regulatory adherence. Upon request, we can offer EP/USP traceable standards. Our products are routinely re-evaluated to maintain consistent quality and performance.